Strathspey Crown Holdings Group, LLC's Form 4 filing
AEON Biopharma, Inc. (AEON) · filed Aug 14, 2023
- Accession no.
- 0001477932-23-006094
- Filed
- Aug 14, 2023
- Trade date
- Aug 11, 2023
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $73.8M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Strathspey Crown Holdings Group, LLCCIK 0001557024 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 11, 2023 | Class A Common Stock | SSaleDisposed | −7,380,394 | $10.00 | −$73,803,940 | 2,031,773 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.